CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- UPLOAD Other SEC-generated Letter
- 4 Planned sale President and CEO sold 21,000 shares at $16.88 ($354,480)
- CORRESP Other Correspondence Between Filers and SEC Staff
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Agreement ended · Results of operations · New debt or obligation
- 4 Shares withheld for taxes COO and SVP, Compliance gave up 1,208 shares (to pay taxes)
- UPLOAD Other SEC-generated Letter
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes COO and SVP, Compliance gave up 3,027 shares (to pay taxes)
- 4 Shares withheld for taxes CFO and Treasurer gave up 7,123 shares (to pay taxes)
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Planned sale President and CEO sold 21,000 shares at $18.66 ($391,860)
- UPLOAD Other SEC-generated Letter
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes CFO and Treasurer gave up 9,838 shares (to pay taxes)
- 4 Planned sale President and CEO sold 21,000 shares at $20.81 ($437,010)
- 4 Open-market sale Director sold 425,621 shares at an average $20.74 ($8,829,333)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 20,000 shares at $20.96 ($419,200)
Page 4 of 50 · 1,000 filings